These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31120716)

  • 1. Evaluation of value-based insurance design for primary care.
    Ma Q; Sylwestrzak G; Oza M; Garneau L; DeVries AR
    Am J Manag Care; 2019 May; 25(5):221-227. PubMed ID: 31120716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Participation in a Value-Based Insurance Design Program With Health Care Spending and Utilization.
    Zhang H; Cowling DW
    JAMA Netw Open; 2023 Mar; 6(3):e232666. PubMed ID: 36912835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of the Out-of-Pocket Charge for Children's Primary Care Visits: An Application of Value-Based Insurance Design.
    Sepúlveda MJ; Roebuck MC; Fronstin P; Vidales-Calderon P; Parikh A; Rhee K
    J Pediatr; 2016 Aug; 175():195-200. PubMed ID: 27189683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization and Cost of an Employer-Sponsored Comprehensive Primary Care Delivery Model.
    Basu S; Zhang T; Gilmore A; Datta E; Kim EY
    JAMA Netw Open; 2020 Apr; 3(4):e203803. PubMed ID: 32352529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of increased cost-sharing on low-value service use.
    Gruber J; Maclean JC; Wright B; Wilkinson E; Volpp KG
    Health Econ; 2020 Oct; 29(10):1180-1201. PubMed ID: 32686138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a large regional health plan's value-based insurance design program on statin use.
    Frank MB; Fendrick AM; He Y; Zbrozek A; Holtz N; Leung S; Chernew ME
    Med Care; 2012 Nov; 50(11):934-9. PubMed ID: 23047782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value-Based Insurance Design: Clinically Nuanced Consumer Cost-Sharing for Mental Health Services.
    Benson NM; Fendrick AM
    J Ment Health Policy Econ; 2023 Sep; 26(3):101-108. PubMed ID: 37772506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of the Medicare Advantage Value-Based Insurance Design Model Test on Utilization in 2017.
    Eibner C; Buttorff C; Cefalu M; Khodyakov D; Taylor EA
    Am J Health Promot; 2022 May; 36(4):740-745. PubMed ID: 35420449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mental Health Parity and Addiction Equity Act evaluation study: Impact on specialty behavioral healthcare utilization and spending among enrollees with substance use disorders.
    Friedman S; Xu H; Harwood JM; Azocar F; Hurley B; Ettner SL
    J Subst Abuse Treat; 2017 Sep; 80():67-78. PubMed ID: 28755776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care utilization by children with chronic illnesses: a comparison of medicaid and employer-insured managed care.
    Shatin D; Levin R; Ireys HT; Haller V
    Pediatrics; 1998 Oct; 102(4):E44. PubMed ID: 9755281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of a value-based insurance design plus health coaching on medication adherence and medical spending.
    Musich S; Wang S; Hawkins K
    Popul Health Manag; 2015 Jun; 18(3):151-8. PubMed ID: 25247449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can broader diffusion of value-based insurance design increase benefits from US health care without increasing costs? Evidence from a computer simulation model.
    Braithwaite RS; Omokaro C; Justice AC; Nucifora K; Roberts MS
    PLoS Med; 2010 Feb; 7(2):e1000234. PubMed ID: 20169114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value-based insurance design program in north Carolina increased medication adherence but was not cost neutral.
    Maciejewski ML; Wansink D; Lindquist JH; Parker JC; Farley JF
    Health Aff (Millwood); 2014 Feb; 33(2):300-8. PubMed ID: 24493774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-sharing payments for out-of-network care in commercially insured adults.
    Xu WY; Dowd BE; Donneyong MM; Li Y; Retchin SM
    Am J Manag Care; 2019 Dec; 25(12):598-604. PubMed ID: 31860228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF; Escarce JJ; Solomon MD; Goldman DP
    JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gatekeeping and patterns of outpatient care post healthcare reform.
    Barnett ML; Song Z; Bitton A; Rose S; Landon BE
    Am J Manag Care; 2018 Oct; 24(10):e312-e318. PubMed ID: 30325192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug use and spending under a formulary informed by cost-effectiveness.
    Yeung K; Cruz M; Tsiao E; Watkins JB; Sullivan SD
    J Manag Care Spec Pharm; 2023 Nov; 29(11):1175-1183. PubMed ID: 37889867
    [No Abstract]   [Full Text] [Related]  

  • 19. Connecticut's Value-Based Insurance Plan Increased The Use Of Targeted Services And Medication Adherence.
    Hirth RA; Cliff EQ; Gibson TB; McKellar MR; Fendrick AM
    Health Aff (Millwood); 2016 Apr; 35(4):637-46. PubMed ID: 27044964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.